
# Phase 4.0 — Biological Validation Preparation Summary

## Objective

This step prepared the final result tables and gene lists needed for biological validation of the T2D gene/protein association prediction framework.

The analysis used the official Phase 3 model:

- Combined Protein+Genomic SVM RBF
- Protein block: ProtBERT sliding-window embeddings
- Genomic block: K3/K4/Basic TSS-proximal regulatory features

## Final Master Comparison

A final master comparison table was created across major experimental phases:

- Protein handcrafted baseline
- Protein foundation embeddings
- Genomic handcrafted regulatory features
- Multimodal protein + genomic integration

The best overall ranking model was:

- Combined Protein+Genomic SVM RBF
- Test ROC-AUC: 0.7290
- Test PR-AUC: 0.7573
- Test F1: 0.6590
- Test MCC: 0.3438

## Extracted Gene Lists

The following gene lists were extracted for biological validation:

- Top 50 combined predictions: 50
- True positives: 86
- High-confidence false positives: 40
- High-confidence false negatives: 49
- True negatives: 96


From Phase 3.2 error comparison:

- Combined-rescued genes: 18
- Protein-correct but lost after integration: 15
- Both-wrong genes: 74


## Recommended Biological Validation

The next step is to validate these gene lists using biological databases and enrichment tools.

Recommended databases/resources:

1. DisGeNET
2. Open Targets
3. GWAS Catalog
4. OMIM
5. KEGG
6. Reactome
7. Gene Ontology Biological Process
8. T2D/insulin/glucose/lipid/inflammation-related pathway gene sets

Recommended validation targets:

1. Top 50 combined predictions
2. Top true positives
3. Combined-rescued genes
4. High-confidence false positives
5. Both-wrong genes

The most important question is whether top-ranked and rescued genes are enriched for diabetes-relevant biological processes such as insulin secretion, glucose homeostasis, lipid metabolism, beta-cell function, inflammatory response, mitochondrial metabolism, PI3K-Akt signaling, AMPK signaling, and PPAR signaling.
